cyclopia sequence: Clinical Trials

26 trials for cyclopia sequence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 terminated, 3 unknown, 3 withdrawn. 26 Phase 1, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 126Completed 15, Terminated 3, Unknown 3, Withdrawn 3, Recruiting 1, Suspended 1
Phase 212Completed 7, Withdrawn 2, Recruiting 1, Terminated 1, Unknown 1

Follow cyclopia sequence: new trials by email Literature Review of cyclopia sequence trials Research Report on cyclopia sequence

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®
Levodopa Cyclops®, INBRIJA® - Parkinson, Parkinson Disease
Phase 1CompletedPureIMS B.V.262023-09-252025-05-31
Minocycline Accelerates Intracerebral Hemorrhage Absorption
Minocycline, starch - Intracerebral Hemorrhage
Phase 1UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine902023-01-012022-11-29
Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
Minocycline - Schizophrenia, Schizoaffective Disorder
Phase 1UnknownPakistan Institute of Living and Learning602022-08-302022-04-29
Minocycline for Chronic Autoimmune Uveitis
minocycline - Minocycline, Uveitis
Phase 1 / Phase 2RecruitingSun Yat-sen University102021-12-012023-04-18
Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention
Intra-arterial cold saline, minocycline, and magnesium - Stroke, Ischemic
Phase 1WithdrawnNorthwell Health2021-06-012026-04-06
Neuroimmune Dysfunction in Alcohol Use Disorder
Minocycline, Sugar pill - Alcohol Drinking, Alcohol-Related Disorders
Phase 1CompletedUniversity of Maryland, Baltimore1422020-02-032023-12-01
A Proof-of-Concept Study of Minocycline in Autism
Minocycline, Placebos - Autism Spectrum Disorder, Autism
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati532019-04-192020-12-08
Minocycline Treatment for Cystoid Macular Edema
minocycline - Minocycline, Cystoid Macular Edema
Phase 1 / Phase 2UnknownSun Yat-sen University52019-01-012023-04-19
Minocycline for Alcohol Use Disorder
Minocycline, Sugar pill - Alcohol Use Disorder, Inflammation
Phase 1 / Phase 2WithdrawnUniversity of California, Los Angeles2018-01-152019-01-24
Measuring Brain Inflammation in Autism
Minocycline - Autism Spectrum Disorder
Phase 1SuspendedUniversity of California, Los Angeles302017-04-112020-08-10
Minocycline Therapy for Management of Adverse Radiation Effects
Minocycline - Irradiation; Adverse Effect
Phase 1TerminatedUniversity of Pittsburgh12015-11-012018-06-25
Minocycline's Effects on Alcohol Responses in Humans
Minocycline, Placebo (for Minocycline) - Alcohol Dependence
Phase 1CompletedYale University542015-07-012020-03-09
The Safety of High Dose Minocycline in the Patient Population Undergoing Carotid Revascularization
Administration of minocycline - Stroke
Phase 1TerminatedUniversity of Pittsburgh62014-07-012017-06-09
Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa
Minocycline - Retinitis Pigmentosa
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)72014-05-012024-04-17
The Effects of Minocycline in Humans
Sugar pill, Minocycline - Memory Impairment
Phase 1CompletedYale University102013-07-082019-09-19
Minocycline Bioequivalence Study
Minocycline - Skin Diseases
Phase 1CompletedGlaxoSmithKline282013-05-012013-11-18
Symptom Burden in Head and Neck Cancer
Placebo, Armodafinil, Minocycline - Head And Neck Cancer
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center12013-03-012015-02-10
A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
Minocycline - Intracerebral Hemorrhage
Phase 1 / Phase 2CompletedAugusta University162013-02-012018-04-26
Minocycline to Treat Branch Retinal Vein Occlusion
Minocycline, Placebo, Bevacizumab - Retinal Vein Occlusion
Phase 1 / Phase 2CompletedNational Eye Institute (NEI)92012-03-282022-01-26
Bioequivalence Minocycline Bioequivalence
Minocycline 100mg - Skin Infections (Acne)
Phase 1CompletedGlaxoSmithKline252011-06-172017-06-22

Showing 20 of 26. Sign in to see all of them.

Narrower conditions

Alcoholism (3)  ·  Macular Edema (3)  ·  Stroke (3)  ·  Alcohol Drinking (2)  ·  Autism Spectrum Disorder (2)  ·  Cerebral Hemorrhage (2)  ·  Cognition Disorders (2)  ·  Inflammation (2)  ·  Mental Disorders (2)  ·  Schizophrenia (2)  ·  Acne Vulgaris (1)  ·  Alcohol-Related Disorders (1)  ·  Aneurysm (1)  ·  Arteriovenous Malformations (1)

Broader conditions

Nervous System Diseases (10)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Cardiovascular Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Vascular Diseases (7)  ·  Cerebrovascular Disorders (5)  ·  Mental Disorders (5)  ·  Pathologic Processes (5)  ·  Eye Diseases (4)  ·  Retinal Diseases (4)  ·  Macular Degeneration (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Retinal Degeneration (3)

Interventions

Minocycline (25)  ·  Sugars (3)  ·  Bupropion (2)  ·  Modafinil (2)  ·  Bevacizumab (1)  ·  Curcumin (1)  ·  Dihydroxyphenylalanine (1)  ·  Doxycycline (1)  ·  Magnesium (1)  ·  Starch (1)  ·  Surveys and Questionnaires (1)  ·  Tetracycline (1)

Sponsors

National Eye Institute (NEI) (3)  ·  GlaxoSmithKline (2)  ·  M.D. Anderson Cancer Center (2)  ·  Sun Yat-sen University (2)  ·  University of California, Los Angeles (2)  ·  University of Pittsburgh (2)  ·  Yale University (2)  ·  Augusta University (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  David Hess, MD (1)  ·  Northwell Health (1)  ·  Pakistan Institute of Living and Learning (1)  ·  PureIMS B.V. (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Stanley Medical Research Institute (1)

Countries

United States (16)  ·  China (2)  ·  Pakistan (2)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Mexico (1)  ·  United Kingdom (1)

Top investigators

Catherine A Cukras, M.D. (2)  ·  Ajay Niranjan, MD, MBA (1)  ·  Allen Lamb, DO (1)  ·  Catherine A Cukras, MD, PhD (1)  ·  Craig Erickson (1)  ·  Dan Liang (1)  ·  David C Hess, MD (1)  ·  David I. Rosenthal, MD, MA, BA (1)  ·  Dr.Inti Qurashi, MD (1)  ·  Georgios A Zenonos, MD (1)  ·  Imran B Chaudhry, MD (1)  ·  Ismene Petrakis, M.D. (1)  ·  Ivo Bogdanov, MD (1)

Results publications

PMID 18212521, PMID 20705929, PMID 22589436, PMID 28887388, PMID 30744442, PMID 36882562, PMID 36912792, PMID 36999619, PMID 40483726

NIH funding

K01AA026005 (2), 2023 (1), R21AA023150 (1)